Form 4: National Healthcare Corp SVP, CFO Brian F. Kidd Reports Acquisition of Restricted Stock and Stock Options
SEC Form 4 Filing
Brian F. Kidd, SVP and CFO of National Healthcare Corp, reports the acquisition of 1,418 shares of restricted common stock and stock options.
Summary
- On March 5, 2025, Brian F. Kidd, SVP and CFO of National Healthcare Corp, reported transactions involving the company's securities.
- Kidd acquired 1,418 shares of common stock.
- These shares were granted as restricted stock, vesting in three equal installments on January 1, 2026, January 1, 2027, and January 1, 2028.
- Kidd also acquired options to purchase 12,000 shares of common stock with an exercise price of $94.10, exercisable from March 5, 2025, and expiring on March 5, 2029.
- Following these transactions, Kidd directly owns 22,681 shares of common stock.
- Kidd also holds options to purchase 37,234 shares of common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard regulatory filing detailing stock transactions by an executive.
Positives
- The acquisition of restricted stock and stock options by a key executive could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The acquisition of shares and options by a key executive could influence investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 02/18/2023 | Date exercisable for options to purchase common stock at $63.96, expiring 02/18/2027. |
| 03/08/2024 | Date exercisable for options to purchase common stock at $53.94, expiring 03/08/2028. |
| 01/01/2026 | First vesting date (33 1/3%) for the restricted shares granted on 03/05/2025. |
| 02/24/2026 | Date exercisable for options to purchase common stock at $90.62, expiring 02/24/2030. |
| 01/01/2027 | Second vesting date (33 1/3%) for the restricted shares granted on 03/05/2025. |
| 01/01/2028 | Final vesting date (33 1/3%) for the restricted shares granted on 03/05/2025. |
| 03/05/2025 | Date of the reported transactions: acquisition of restricted stock and stock options. |
| 03/05/2029 | Expiration date for options to purchase common stock at $94.10. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.